7 Evolution of cross-resistance to CD8+ T cells in the course of BRAF and MEK inhibitor treatment in BRAFV600E melanoma
Zhao, F, Pieper, N, Harbers, FN, Zaremba, A, Sucker, A, Lennerz, V, Wölfel, T, Schadendorf, D, Paschen, A
Published in ESMO open (01.07.2018)
Published in ESMO open (01.07.2018)
Get full text
Journal Article